The institutional investor owned 13,408 shares of the biopharmaceutical company’s stock after selling 537 shares during the quarter. Powers Advisory Group LLC’s holdings in Pfizer were worth $325,000 at the end of the most recent quarter. Amundi now owns 52,090,403 shares of the biopharmaceutical company’s stock valued at $1,265,277,000 after acquiring an additional 15,758,846 shares during the last quarter. Nuveen LLC acquired a new stake in Pfizer in the 1st quarter valued at about $389,861,000. Goldman Sachs Group Inc. now owns 26,456,457 shares of the biopharmaceutical company’s stock valued at $670,407,000 after acquiring an additional 9,041,990 shares during the last quarter.